China Medical System Holdings Limited (FRA:2M7C)
Germany · Delayed Price · Currency is EUR 1.480
+0.020 (1.37%)
At close: Jan 30, 2026
FRA:2M7C Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1,651 | 1,620 | 2,401 | 3,259 | 3,017 | 2,530 |
Depreciation & Amortization | 269.23 | 259.24 | 229.57 | 227.23 | 219.82 | 208.32 |
Other Amortization | - | - | 23.45 | - | - | - |
Loss (Gain) From Sale of Assets | -0.5 | -0.5 | 0.27 | 0.4 | 0.23 | 0.15 |
Asset Writedown & Restructuring Costs | 1.15 | 1.15 | 171.49 | 62 | 20 | 227.6 |
Loss (Gain) From Sale of Investments | 109.03 | 109.03 | 60.75 | -150.01 | -115.66 | 0.57 |
Loss (Gain) on Equity Investments | -341.3 | -341.3 | -277.87 | -65.06 | -75.35 | -153.8 |
Stock-Based Compensation | - | - | -35.87 | 18.72 | 17.16 | - |
Provision & Write-off of Bad Debts | -0.5 | -0.5 | 52.72 | 0.11 | 1.31 | - |
Other Operating Activities | -606.97 | -250.21 | -125.56 | 110.79 | 5.03 | -209.57 |
Change in Accounts Receivable | -173.42 | -173.42 | 410.56 | 163.91 | -367.89 | -132.77 |
Change in Inventory | -130.5 | -130.5 | -235.77 | 8.16 | -90.87 | 25.84 |
Change in Accounts Payable | 47.82 | 47.82 | -82.85 | -71.86 | -33.87 | 246.49 |
Change in Unearned Revenue | 3.88 | 3.88 | -8.88 | -2.1 | 9.31 | 1.47 |
Change in Other Net Operating Assets | 124.08 | 124.08 | -80.1 | -8.04 | -112.77 | -52.65 |
Operating Cash Flow | 952.52 | 1,269 | 2,503 | 3,553 | 2,494 | 2,692 |
Operating Cash Flow Growth | -49.47% | -49.32% | -29.56% | 42.48% | -7.36% | 5.36% |
Capital Expenditures | -35.59 | -32.62 | -27.49 | -18.34 | -23.35 | -37.56 |
Sale of Property, Plant & Equipment | 4.09 | 4.09 | 0.32 | 2.32 | 3 | 0.37 |
Cash Acquisitions | - | - | - | -29 | -533.91 | - |
Divestitures | - | - | -11.16 | - | - | - |
Sale (Purchase) of Intangibles | -191.8 | -423.29 | -275.77 | -506.59 | -161.49 | -303.86 |
Investment in Securities | -507.69 | -403.8 | -470.14 | -726.06 | -898.54 | -156.92 |
Other Investing Activities | 364.2 | 312.75 | 341.96 | 134.27 | 126.64 | 144.15 |
Investing Cash Flow | -439.01 | -615.1 | -442.28 | -1,178 | -1,520 | -353.82 |
Long-Term Debt Issued | - | 831.3 | 1,277 | 1,375 | 1,077 | 630.59 |
Total Debt Issued | 715 | 831.3 | 1,277 | 1,375 | 1,077 | 630.59 |
Long-Term Debt Repaid | - | -1,296 | -1,805 | -1,445 | -11.81 | -707.05 |
Total Debt Repaid | -1,129 | -1,296 | -1,805 | -1,445 | -11.81 | -707.05 |
Net Debt Issued (Repaid) | -414.49 | -465.07 | -528.26 | -69.83 | 1,066 | -76.45 |
Repurchase of Common Stock | - | -238.39 | - | -48.38 | -151.52 | -86.96 |
Common Dividends Paid | -648.34 | -556.16 | -1,360 | -1,276 | -1,155 | -834.13 |
Other Financing Activities | 79.75 | -1.42 | -236.4 | -5.46 | -17.61 | -37.01 |
Financing Cash Flow | -983.08 | -1,261 | -2,125 | -1,400 | -258.39 | -1,035 |
Foreign Exchange Rate Adjustments | 9.27 | 3.04 | -0.87 | 15.51 | 1.38 | -0.23 |
Net Cash Flow | -460.3 | -604.56 | -65.32 | 990.64 | 717.31 | 1,303 |
Free Cash Flow | 916.93 | 1,236 | 2,475 | 3,535 | 2,471 | 2,654 |
Free Cash Flow Growth | -50.77% | -50.07% | -29.97% | 43.08% | -6.93% | 5.44% |
Free Cash Flow Margin | 11.67% | 16.55% | 30.89% | 38.63% | 29.63% | 38.22% |
Free Cash Flow Per Share | 0.38 | 0.51 | 1.01 | 1.44 | 1.00 | 1.07 |
Cash Interest Paid | 20.45 | 38.61 | 45.21 | 37.55 | 17.61 | 27.2 |
Cash Income Tax Paid | 538.55 | 538.55 | 547.05 | 450.5 | 396.73 | 446.97 |
Levered Free Cash Flow | 451.21 | 544.94 | 1,551 | 2,091 | 1,350 | 1,516 |
Unlevered Free Cash Flow | 468.86 | 569.07 | 1,580 | 2,122 | 1,368 | 1,533 |
Change in Working Capital | -128.15 | -128.15 | 2.97 | 90.08 | -596.07 | 88.38 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.